Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
British Journal of Haematology
|
September 9, 2024
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
Martin Kaiser, Vicky Goh, Simon Stern, et al.
British Journal of Haematology
|
April 27, 2011
Guidelines for supportive care in multiple myeloma 2011
John A Snowden, Sam H Ahmedzai, John Ashcroft, et al.
Blood Cancer Journal
|
March 16, 2023
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic
Jonathan Carmichael, Frances Seymour, Graham McIlroy, et al.
British Journal of Haematology
|
February 16, 2008
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)
Sylvia Feyler, Sheila J M O'Connor, Andy C Rawstron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2011
A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment
Ping Wu, Brian A Walker, Daniel Brewer, et al.
Blood
|
October 18, 2002
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation
Andy C Rawstron, Faith E Davies, Ranjit DasGupta, et al.
British Journal of Haematology
|
January 8, 2025
Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paper
Jennifer Pinney, Candice Roufosse, Andreas Kousios, et al.
Blood
|
April 14, 2012
Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial
Gareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Bone Marrow Transplantation
|
June 29, 2022
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study
John A Snowden, Sam H Ahmedzai, Angela Cox, et al.
Blood
|
June 7, 2003
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma
Ranjit K Dasgupta, Peter J Adamson, Faith E Davies, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
British Journal of Haematology
|
September 9, 2024
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
Martin Kaiser, Vicky Goh, Simon Stern, et al.
British Journal of Haematology
|
April 27, 2011
Guidelines for supportive care in multiple myeloma 2011
John A Snowden, Sam H Ahmedzai, John Ashcroft, et al.
Blood Cancer Journal
|
March 16, 2023
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic
Jonathan Carmichael, Frances Seymour, Graham McIlroy, et al.
British Journal of Haematology
|
February 16, 2008
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)
Sylvia Feyler, Sheila J M O'Connor, Andy C Rawstron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2011
A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment
Ping Wu, Brian A Walker, Daniel Brewer, et al.
Blood
|
October 18, 2002
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation
Andy C Rawstron, Faith E Davies, Ranjit DasGupta, et al.
British Journal of Haematology
|
January 8, 2025
Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paper
Jennifer Pinney, Candice Roufosse, Andreas Kousios, et al.
Blood
|
April 14, 2012
Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial
Gareth J Morgan, Faith E Davies, Walter M Gregory, et al.
Bone Marrow Transplantation
|
June 29, 2022
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study
John A Snowden, Sam H Ahmedzai, Angela Cox, et al.
Blood
|
June 7, 2003
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma
Ranjit K Dasgupta, Peter J Adamson, Faith E Davies, et al.
Page
of 4